Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants

Clinical trial NCT07039929 · TERMINATED

Trial details

NCT number: NCT07039929
Sponsor: Incyte Corporation
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2025-07-28
Primary completion: 2025-10-11
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.